Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.965 USD | -0.84% | -8.26% | +202.27% |
04-18 | JonesTrading Starts Rezolute With Buy Rating, $10 Price Target | MT |
03-06 | Rezolute, Inc. Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+202.27% | 120M | |
+4.50% | 109B | |
+11.21% | 105B | |
+1.08% | 22.25B | |
-11.74% | 22.09B | |
-8.05% | 18.68B | |
-38.36% | 17.58B | |
-10.24% | 16.85B | |
+4.74% | 13.76B | |
+37.92% | 12.46B |
- Stock Market
- Equities
- RZLT Stock
- News Rezolute, Inc.
- JonesTrading Starts Rezolute With Buy Rating, $10 Price Target